Frontage Laboratories, Inc. acquired Teddy Clinical Research Laboratory Co., Ltd from Hangzhou Tigermed Consulting Co., Ltd and Jiaxing Xinge Medical Consulting Co., Ltd.
Frontage Laboratories, Inc. entered into an Share Transfer Agreement to acquire Teddy Clinical Research Laboratory (Shanghai) Co., Ltd from Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) and Jiaxing Xinge Medical Consulting Co., Ltd. for CNY 270 million on October 10, 2025.
The completion of the Disposal is contingent upon the fulfillment of the conditions precedent outlined in the Share Transfer Agreement, including the requirement for Frontage Holding to obtain independent shareholders? approval at a general meeting.
Frontage Laboratories, Inc. completed the acquisition of Teddy Clinical Research Laboratory (Shanghai) Co., Ltd from Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) and Jiaxing Xinge Medical Consulting Co., Ltd. on March 3, 2026. The Board is pleased to announce that all the conditions precedent as set out in the Share Transfer Agreement have been satisfied.
Hangzhou Tigermed Consulting Co, Ltd. specialises in providing professional services to pharmaceutical and biotech companies. The group supports its clients in all processes of clinical development and product commercialization. Net sales break down by activity as follows:
- provision of clinical trial services and related technological services (51.8%);
- provision of clinical research consulting services (48.2%).
China accounts for 46% of sales.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Frontage Laboratories, Inc. acquired Teddy Clinical Research Laboratory Co., Ltd from Hangzhou Tigermed Consulting Co., Ltd and Jiaxing Xinge Medical Consulting Co., Ltd.
